Tags

Type your tag names separated by a space and hit enter

Improvement in Sjögren's syndrome following therapy with rituximab for marginal zone lymphoma.
Arthritis Rheum. 2003 Jun 15; 49(3):394-8.AR

Authors+Show Affiliations

University of Pennsylvania Cancer Center, Philadelphia, USA. somerb@mail.med.upenn.eduNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

12794796

Citation

Somer, Bradley G., et al. "Improvement in Sjögren's Syndrome Following Therapy With Rituximab for Marginal Zone Lymphoma." Arthritis and Rheumatism, vol. 49, no. 3, 2003, pp. 394-8.
Somer BG, Tsai DE, Downs L, et al. Improvement in Sjögren's syndrome following therapy with rituximab for marginal zone lymphoma. Arthritis Rheum. 2003;49(3):394-8.
Somer, B. G., Tsai, D. E., Downs, L., Weinstein, B., & Schuster, S. J. (2003). Improvement in Sjögren's syndrome following therapy with rituximab for marginal zone lymphoma. Arthritis and Rheumatism, 49(3), 394-8.
Somer BG, et al. Improvement in Sjögren's Syndrome Following Therapy With Rituximab for Marginal Zone Lymphoma. Arthritis Rheum. 2003 Jun 15;49(3):394-8. PubMed PMID: 12794796.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Improvement in Sjögren's syndrome following therapy with rituximab for marginal zone lymphoma. AU - Somer,Bradley G, AU - Tsai,Donald E, AU - Downs,Lisa, AU - Weinstein,Barry, AU - Schuster,Stephen J, AU - ,, PY - 2003/6/10/pubmed PY - 2003/7/4/medline PY - 2003/6/10/entrez SP - 394 EP - 8 JF - Arthritis and rheumatism JO - Arthritis Rheum. VL - 49 IS - 3 SN - 0004-3591 UR - https://www.unboundmedicine.com/medline/citation/12794796/Improvement_in_Sjögren's_syndrome_following_therapy_with_rituximab_for_marginal_zone_lymphoma_ L2 - https://doi.org/10.1002/art.11109 DB - PRIME DP - Unbound Medicine ER -